{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:56:59Z","timestamp":1792205819829,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018M3A9H3024611"],"award-info":[{"award-number":["NRF-2018M3A9H3024611"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41590-020-00860-7","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T12:06:51Z","timestamp":1613045211000},"page":"336-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["Tumor hypoxia represses \u03b3\u03b4 T cell-mediated antitumor immunity against brain tumors"],"prefix":"10.1038","volume":"22","author":[{"given":"Jang Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-4501","authenticated-orcid":false,"given":"Chae Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3370-8438","authenticated-orcid":false,"given":"Hyeon Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-4150","authenticated-orcid":false,"given":"Yujin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-1510","authenticated-orcid":false,"given":"Heung Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"860_CR1","first-page":"215","volume":"19","author":"H Salmon","year":"2019","unstructured":"Salmon, H., Remark, R., Gnjatic, S. & Merad, M. Host tissue determinants of tumour immunity. Nat. Rev. Cancer 19, 215\u2013227 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"860_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830.e14 (2018).","journal-title":"Immunity"},{"key":"860_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis, C. D., Ferraro, G. B. & Jain, R. K. The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases. Nat. Rev. Cancer 20, 26\u201341 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"860_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim, M., Xia, Y., Bettegowda, C. & Weller, M. Current state of immunotherapy for glioblastoma. Nat. Rev. Clin. Oncol. 15, 422\u2013442 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"860_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/bjc.2017.220","volume":"117","author":"TA Barnes","year":"2017","unstructured":"Barnes, T. A. & Amir, E. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br. J. Cancer 117, 451\u2013460 (2017).","journal-title":"Br. J. Cancer"},{"key":"860_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/cmi.2017.143","volume":"15","author":"L Zhai","year":"2018","unstructured":"Zhai, L. et al. IDO1 in cancer: a Gemini of immune checkpoints. Cell. Mol. Immunol. 15, 447\u2013457 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"860_CR7","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-17-0894","volume":"24","author":"DB Rivadeneira","year":"2018","unstructured":"Rivadeneira, D. B. & Delgoffe, G. M. Antitumor T-cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy. Clin. Cancer Res. 24, 2473\u20132481 (2018).","journal-title":"Clin. Cancer Res."},{"key":"860_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/vaccines4040046","volume":"4","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. & Delgoffe, G. M. Tumor microenvironment metabolism: a new checkpoint for anti-tumor immunity. Vaccines 4, 46 (2016).","journal-title":"Vaccines"},{"key":"860_CR9","doi-asserted-by":"publisher","first-page":"e124989","DOI":"10.1172\/jci.insight.124989","volume":"4","author":"YG Najjar","year":"2019","unstructured":"Najjar, Y. G. et al. Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma. JCI Insight 4, e124989 (2019).","journal-title":"JCI Insight"},{"key":"860_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","volume":"5","author":"NE Scharping","year":"2017","unstructured":"Scharping, N. E., Menk, A. V., Whetstone, R. D., Zeng, X. & Delgoffe, G. M. Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia. Cancer Immunol. Res. 5, 9\u201316 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"860_CR11","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","volume":"20","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nat. Immunol. 20, 1656\u20131667 (2019).","journal-title":"Nat. Immunol."},{"key":"860_CR12","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1172\/JCI96268","volume":"128","author":"P Jayaprakash","year":"2018","unstructured":"Jayaprakash, P. et al. Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. J. Clin. Invest. 128, 5137\u20135149 (2018).","journal-title":"J. Clin. Invest."},{"key":"860_CR13","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1172\/JCI84427","volume":"126","author":"AT Henze","year":"2016","unstructured":"Henze, A. T. & Mazzone, M. The impact of hypoxia on tumor-associated macrophages. J. Clin. Invest. 126, 3672\u20133679 (2016).","journal-title":"J. Clin. Invest."},{"key":"860_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/neuonc\/not148","volume":"16","author":"RL Jensen","year":"2014","unstructured":"Jensen, R. L. et al. Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro Oncol. 16, 280\u2013291 (2014).","journal-title":"Neuro Oncol."},{"key":"860_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3389\/fimmu.2019.00555","volume":"10","author":"M Lee","year":"2019","unstructured":"Lee, M. et al. Preferential infiltration of unique V\u03b39J\u03b32-V\u03b42 T cells into glioblastoma multiforme. Front. Immunol. 10, 555 (2019).","journal-title":"Front. Immunol."},{"key":"860_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11060-010-0245-2","volume":"101","author":"NL Bryant","year":"2011","unstructured":"Bryant, N. L. et al. Preclinical evaluation of ex vivo expanded\/activated \u03b3\u03b4 T cells for immunotherapy of glioblastoma multiforme. J. Neurooncol. 101, 179\u2013188 (2011).","journal-title":"J. Neurooncol."},{"key":"860_CR17","doi-asserted-by":"publisher","first-page":"e0122387","DOI":"10.1371\/journal.pone.0122387","volume":"10","author":"BH Beck","year":"2015","unstructured":"Beck, B. H. et al. Dynamics of circulating \u03b3\u03b4 T cell activity in an immunocompetent mouse model of high-grade glioma. PLoS ONE 10, e0122387 (2015).","journal-title":"PLoS ONE"},{"key":"860_CR18","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1158\/0008-5472.CAN-16-2490","volume":"77","author":"FS Varn","year":"2017","unstructured":"Varn, F. S., Wang, Y., Mullins, D. W., Fiering, S. & Cheng, C. Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment. Cancer Res. 77, 1271\u20131282 (2017).","journal-title":"Cancer Res."},{"key":"860_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee, J. H. et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560, 243\u2013247 (2018).","journal-title":"Nature"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\u201344 (2019).","journal-title":"Nat. Biotechnol."},{"key":"860_CR21","doi-asserted-by":"publisher","unstructured":"Parajuli, P. & Mittal, S. Role of IL-17 in glioma progression. J. Spine Neurosurg. https:\/\/doi.org\/10.4172\/2325-9701.S1-004 (2013).","DOI":"10.4172\/2325-9701.S1-004"},{"key":"860_CR22","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.4110\/in.2020.20.e6","volume":"20","author":"DS Kuen","year":"2020","unstructured":"Kuen, D. S., Kim, B. S. & Chung, Y. IL-17-producing cells in tumor immunity: friends or foes? Immune Netw. 20, e6 (2020).","journal-title":"Immune Netw."},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova, I. & Korbonits, M. Metformin\u2014mode of action and clinical implications for diabetes and cancer. Nat. Rev. Endocrinol. 10, 143\u2013156 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"860_CR24","first-page":"2393","volume":"11","author":"W Duan","year":"2019","unstructured":"Duan, W. et al. Metformin mitigates autoimmune insulitis by inhibiting TH1 and TH17 responses while promoting Treg production. Am. J. Transl. Res. 11, 2393\u20132402 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"860_CR25","doi-asserted-by":"publisher","first-page":"eaax2861","DOI":"10.1126\/sciadv.aax2861","volume":"6","author":"Y Brill-Karniely","year":"2020","unstructured":"Brill-Karniely, Y. et al. Triangular correlation (TrC) between cancer aggressiveness, cell uptake capability, and cell deformability. Sci. Adv. 6, eaax2861 (2020).","journal-title":"Sci. Adv."},{"key":"860_CR26","doi-asserted-by":"publisher","first-page":"e0123721","DOI":"10.1371\/journal.pone.0123721","volume":"10","author":"J Sesen","year":"2015","unstructured":"Sesen, J. et al. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLoS ONE 10, e0123721 (2015).","journal-title":"PLoS ONE"},{"key":"860_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cmet.2016.03.006","volume":"23","author":"RJ Dowling","year":"2016","unstructured":"Dowling, R. J. et al. Metformin pharmacokinetics in mouse tumors: implications for human therapy. Cell Metab. 23, 567\u2013568 (2016).","journal-title":"Cell Metab."},{"key":"860_CR28","first-page":"4509","volume":"30","author":"T Suzuki","year":"2010","unstructured":"Suzuki, T. et al. The antitumour effect of \u03b3\u03b4 T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands. Anticancer Res. 30, 4509\u20134513 (2010).","journal-title":"Anticancer Res."},{"key":"860_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/ni.1717","volume":"10","author":"JC Ribot","year":"2009","unstructured":"Ribot, J. C. et al. CD27 is a thymic determinant of the balance between interferon-\u03b3- and interleukin 17-producing \u03b3\u03b4 T cell subsets. Nat. Immunol. 10, 427\u2013436 (2009).","journal-title":"Nat. Immunol."},{"key":"860_CR30","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.celrep.2017.05.071","volume":"19","author":"N Sumaria","year":"2017","unstructured":"Sumaria, N., Grandjean, C. L., Silva-Santos, B. & Pennington, D. J. Strong TCR\u03b3\u03b4 signaling prohibits thymic development of IL-17A-secreting \u03b3\u03b4 T cells. Cell Rep. 19, 2469\u20132476 (2017).","journal-title":"Cell Rep."},{"key":"860_CR31","doi-asserted-by":"publisher","first-page":"e00390","DOI":"10.1128\/MCB.00390-18","volume":"39","author":"JS Han","year":"2019","unstructured":"Han, J. S. et al. Hypoxia restrains lipid utilization via protein kinase A and adipose triglyceride lipase downregulation through hypoxia-inducible factor. Mol. Cell. Biol. 39, e00390 (2019).","journal-title":"Mol. Cell. Biol."},{"key":"860_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09549-8","volume":"7","author":"V Simko","year":"2017","unstructured":"Simko, V. et al. Hypoxia induces cancer-associated cAMP\/PKA signalling through HIF-mediated transcriptional control of adenylyl cyclases VI and VII. Sci. Rep. 7, 10121 (2017).","journal-title":"Sci. Rep."},{"key":"860_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991\u2013999 (2015).","journal-title":"J. Exp. Med."},{"key":"860_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","volume":"36","author":"A Louveau","year":"2015","unstructured":"Louveau, A., Harris, T. H. & Kipnis, J. Revisiting the mechanisms of CNS immune privilege. Trends Immunol. 36, 569\u2013577 (2015).","journal-title":"Trends Immunol."},{"key":"860_CR35","first-page":"58","volume":"29","author":"PB Medawar","year":"1948","unstructured":"Medawar, P. B. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58\u201369 (1948).","journal-title":"Br. J. Exp. Pathol."},{"key":"860_CR36","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1073\/pnas.1714089115","volume":"115","author":"D Taggart","year":"2018","unstructured":"Taggart, D. et al. Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking. Proc. Natl Acad. Sci. USA 115, E1540\u2013E1549 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"860_CR37","doi-asserted-by":"publisher","first-page":"e101764","DOI":"10.1371\/journal.pone.0101764","volume":"9","author":"Z Belcaid","year":"2014","unstructured":"Belcaid, Z. et al. Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model. PLoS ONE 9, e101764 (2014).","journal-title":"PLoS ONE"},{"key":"860_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2567.2012.03582.x","volume":"136","author":"DJ Pang","year":"2012","unstructured":"Pang, D. J., Neves, J. F., Sumaria, N. & Pennington, D. J. Understanding the complexity of \u03b3\u03b4 T-cell subsets in mouse and human. Immunology 136, 283\u2013290 (2012).","journal-title":"Immunology"},{"key":"860_CR39","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.1158\/1078-0432.CCR-19-0375","volume":"25","author":"C Chauvin","year":"2019","unstructured":"Chauvin, C. et al. NKG2D controls natural reactivity of V\u03b39V\u03b42 T lymphocytes against mesenchymal glioblastoma cells. Clin. Cancer Res. 25, 7218\u20137228 (2019).","journal-title":"Clin. Cancer Res."},{"key":"860_CR40","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","volume":"27","author":"CA Lyssiotis","year":"2017","unstructured":"Lyssiotis, C. A. & Kimmelman, A. C. Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 27, 863\u2013875 (2017).","journal-title":"Trends Cell Biol."},{"key":"860_CR41","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/0008-5472.CAN-17-2460","volume":"78","author":"L Li","year":"2018","unstructured":"Li, L. et al. Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer. Cancer Res. 78, 1779\u20131791 (2018).","journal-title":"Cancer Res."},{"key":"860_CR42","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1073\/pnas.1417636112","volume":"112","author":"S Eikawa","year":"2015","unstructured":"Eikawa, S. et al. Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proc. Natl Acad. Sci. USA 112, 1809\u20131814 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"860_CR43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","volume":"17","author":"S Nakae","year":"2002","unstructured":"Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375\u2013387 (2002).","journal-title":"Immunity"},{"key":"860_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1084\/jem.20170123","volume":"215","author":"IK Kim","year":"2018","unstructured":"Kim, I. K. et al. Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality. J. Exp. Med. 215, 963\u2013983 (2018).","journal-title":"J. Exp. Med."},{"key":"860_CR45","doi-asserted-by":"publisher","first-page":"47440","DOI":"10.18632\/oncotarget.17663","volume":"8","author":"DS Oh","year":"2017","unstructured":"Oh, D. S. et al. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses. Oncotarget 8, 47440\u201347453 (2017).","journal-title":"Oncotarget"},{"key":"860_CR46","doi-asserted-by":"publisher","unstructured":"Oh, D.S., Park, J.H., Jung, H.E., Kim, H.J. & Lee, H.K. Autophagic protein ATG5 controls antiviral immunity via glycolytic reprogramming of dendritic cells against respiratory syncytial virus infection. Autophagy https:\/\/doi.org\/10.1080\/15548627.2020.1812218 (2020).","DOI":"10.1080\/15548627.2020.1812218"},{"key":"860_CR47","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1101\/gr.165126.113","volume":"24","author":"ZS Bao","year":"2014","unstructured":"Bao, Z. S. et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1\u2013MET fusion transcript in secondary glioblastomas. Genome Res. 24, 1765\u20131773 (2014).","journal-title":"Genome Res."},{"key":"860_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.24","volume":"4","author":"Z Zhao","year":"2017","unstructured":"Zhao, Z. et al. Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas. Sci. Data 4, 170024 (2017).","journal-title":"Sci. Data"},{"key":"860_CR49","doi-asserted-by":"publisher","unstructured":"Goldman, M. et al. The UCSC Xena platform for public and private cancer genomics data visualization and interpretation. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/326470 (2019).","DOI":"10.1101\/326470"},{"key":"860_CR50","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.3389\/fimmu.2020.02145","volume":"11","author":"JH Park","year":"2020","unstructured":"Park, J. H. & Lee, H. K. Re-analysis of single cell transcriptome reveals that the NR3C1\u2013CXCL8\u2013neutrophil axis determines the severity of COVID-19. Front. Immunol. 11, 2145 (2020).","journal-title":"Front. Immunol."},{"key":"860_CR51","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00860-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T17:05:22Z","timestamp":1674925522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00860-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1038\/s41590-020-00860-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739542071.793584157","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"23 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}